Graphical Abstract Access this article Similar content being viewed by others Data Availability All the data has been incorporated in this manuscript
The FDA also determined on February 21, 2025, that the shortage of semaglutide injection products has been resolved and that the agency may take action against compounders for violations of statutory and regulatory requirements
Second, storage compromise
Vegetarian capsules
As I see it, they might be suspicious, they might ask questions, but they have no actual basis to refuse it
Compounding this plateau, placebo-controlled cardiovascular outcome trials (CVOTs) are increasingly deemed unethical in patients with established CVD, as current standards of care now include agents with proven cardiovascular efficacy, namely GLP-1RA and SGLT-2 inhibitors